Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF in Early Stage Parkinson's Disease
NCT01227681Phase 2Terminated
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Jun 2010
- Primary completion
- Dec 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in Parkinson's disease (PD), sponsored by Buddhist Tzu Chi General Hospital. Started Jun 2010; status: terminated.
02
Drugs
filgrastim
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01227681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227681.